For example, hepatitis B patients, accounting for more than 70% of our study population, usually receive antihepatitis B immunoglobulin with or without oral nuclos(t)ide in Korea, resulting in an extremely low rate of disease recurrence after LT [24]. Here, PPIB is linked to hepatitis B virus infection.